New Leaf Venture Partners’s Iterum Therapeutics ITRM Stock Holding History

New Leaf Venture Partners’s Portfolio ITRM Stock Details ITRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-345,020	Closed	-$343K	–	8
2025 Q2	$343K	Hold	345,020	–	–	0.65%	8
2025 Q1	$424K	Hold	345,020	–	–	0.95%	8
2024 Q4	$611K	Hold	345,020	–	–	0.82%	9
2024 Q3	$376K	Buy	345,020 +247,934	+255%	+$295K	0.39%	9
2024 Q2	$111K	Buy	97,086 +2	+0%	+$3	0.14%	10
2024 Q1	$150K	Hold	97,084	–	–	0.13%	11
2023 Q4	$191K	Hold	97,084	–	–	0.15%	12
2023 Q3	$77.7K	Hold	97,084	–	–	0.1%	12
2023 Q2	$104K	Hold	97,084	–	–	0.09%	14
2023 Q1	$97.1K	Hold	97,084	–	–	0.08%	17
2022 Q4	$81.6K	Hold	97,084	–	–	0.06%	17
2022 Q3	$157K	Sell	97,084 -3	-0%	-$9	0.09%	18
2022 Q2	$292K	Hold	97,087	–	–	0.19%	19
2022 Q1	$517K	Hold	97,087	–	–	0.25%	19
2021 Q4	$571K	Hold	97,087	–	–	0.21%	21
2021 Q3	$813K	Hold	97,087	–	–	0.23%	21
2021 Q2	$2.73M	Hold	97,087	–	–	0.7%	15
2021 Q1	$2.05M	Hold	97,087	–	–	0.48%	17
2020 Q4	$1.44M	Hold	97,087	–	–	0.33%	16
2020 Q3	$1.53M	Hold	97,087	–	–	0.62%	16
2020 Q2	$1.73M	Hold	97,087	–	–	0.5%	16
2020 Q1	$3.95M	Hold	97,087	–	–	1.18%	11
2019 Q4	$6.55M	Hold	97,087	–	–	1.42%	9
2019 Q3	$8.4M	Hold	97,087	–	–	2.54%	8
2019 Q2	$10M	Hold	97,087	–	–	2.69%	9
2019 Q1	$11.5M	Hold	97,087	–	–	3.16%	8
2018 Q4	$7.3M	Hold	97,087	–	–	2%	10
2018 Q3	$9.65M	Hold	97,087	–	–	1.76%	10
2018 Q2	$15.5M	Buy	+97,087	New	+$17.5M	3.75%	7

Other funds holding ITRM

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Apollon Financial Mount Pleasant, South Carolina $848M AUM 27.31% 1-Year Est. Return

OIA

OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

GWP

Gen-Wealth Partners Zeeland, Michigan $360M AUM 27.44% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

New Leaf Venture Partners's ITRM Position: Q3 2025 in Review

New Leaf Venture Partners sold out of Iterum Therapeutics (ITRM) in Q3 2025, closing a stake of 345,020 shares — an estimated $343K sold.

New Leaf Venture Partners first reported a position in ITRM in Q2 2018 and held it in 29 quarters. The position peaked at $15.5M in Q2 2018. 24 funds tracked by Wall St. Rank hold ITRM as of Q3 2025.

New Leaf Venture Partners reported no remaining Iterum Therapeutics position as of Q3 2025 after selling out during the quarter.
New Leaf Venture Partners sold 345,020 Iterum Therapeutics shares in Q3 2025, an estimated $343K.
New Leaf Venture Partners first reported a position in Iterum Therapeutics in Q2 2018 and held it in 29 quarters.
New Leaf Venture Partners's Iterum Therapeutics position peaked at $15.5M in Q2 2018.
24 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q3 2025.

Based on New Leaf Venture Partners's 13F filing for Q3 2025, filed 14 Nov 2025.